hello everyone. this question we have to make an advertisement on a ayurvedic company telling about coronavirus precautions if you don't know this language then u can tell me in english also I will translate it .
Attachments:
Answers
Answered by
0
Answer:
Till a couple of weeks back, Indian and international health advisories were recommending that
mask
usage be limited to those with
COVID-19
symptoms and healthcare workers. Now, that position has changed. In its latest advisory, the Health Ministry has said that "certain countries have claimed benefits of homemade face cover for the general public." Advising people to wear face covers, particularly when stepping out, the advisory said that it will "help in protecting the community at large."
Answered by
0
Here is your answer
COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.
Most common symptoms:
fever
dry cough
tiredness
Less common symptoms:
aches and pains
sore throat
diarrhoea
conjunctivitis
headache
loss of taste or smell
a rash on skin, or discolouration of fingers or toes
Symptoms of severe COVID‐19 disease include:
Shortness of breath,
Loss of appetite,
Confusion,
Persistent pain or pressure in the chest,
High temperature (above 38 °C).
Other less common symptoms are:
Irritability,
Confusion,
Reduced consciousness (sometimes associated with seizures),
Anxiety,
Depression,
Sleep disorders,
More severe and rare neurological complications such as strokes, brain inflammation, delirium and nerve damage.
People of all ages who experience fever and/or cough associated with difficulty breathing or shortness of breath, chest pain or pressure, or loss of speech or movement should seek medical care immediately. If possible, call your health care provider, hotline or health facility first, so you can be directed to the right clinic.
The first mass vaccination programme started in early December 2020 and the number of vaccination doses administered is updated on a daily basis here. At least 13 different vaccines (across 4 platforms) have been administered. Campaigns have started in 206 economies.
The Pfizer/BioNtech Comirnaty vaccine was listed for WHO Emergency Use Listing (EUL) on 31 December 2020. The SII/Covishield and AstraZeneca/AZD1222 vaccines (developed by AstraZeneca/Oxford and manufactured by the Serum Institute of India and SK Bio respectively) were given EUL on 16 February. The Janssen/Ad26.COV 2.S developed by Johnson & Johnson, was listed for EUL on 12 March 2021. The Moderna COVID-19 vaccine (mRNA 1273) was listed for EUL on 30 April 2021 and the Sinopharm COVID-19 vaccine was listed for EUL on 7 May 2021. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.
Most common symptoms:
fever
dry cough
tiredness
Less common symptoms:
aches and pains
sore throat
diarrhoea
conjunctivitis
headache
loss of taste or smell
a rash on skin, or discolouration of fingers or toes
Symptoms of severe COVID‐19 disease include:
Shortness of breath,
Loss of appetite,
Confusion,
Persistent pain or pressure in the chest,
High temperature (above 38 °C).
Other less common symptoms are:
Irritability,
Confusion,
Reduced consciousness (sometimes associated with seizures),
Anxiety,
Depression,
Sleep disorders,
More severe and rare neurological complications such as strokes, brain inflammation, delirium and nerve damage.
People of all ages who experience fever and/or cough associated with difficulty breathing or shortness of breath, chest pain or pressure, or loss of speech or movement should seek medical care immediately. If possible, call your health care provider, hotline or health facility first, so you can be directed to the right clinic.
The first mass vaccination programme started in early December 2020 and the number of vaccination doses administered is updated on a daily basis here. At least 13 different vaccines (across 4 platforms) have been administered. Campaigns have started in 206 economies.
The Pfizer/BioNtech Comirnaty vaccine was listed for WHO Emergency Use Listing (EUL) on 31 December 2020. The SII/Covishield and AstraZeneca/AZD1222 vaccines (developed by AstraZeneca/Oxford and manufactured by the Serum Institute of India and SK Bio respectively) were given EUL on 16 February. The Janssen/Ad26.COV 2.S developed by Johnson & Johnson, was listed for EUL on 12 March 2021. The Moderna COVID-19 vaccine (mRNA 1273) was listed for EUL on 30 April 2021 and the Sinopharm COVID-19 vaccine was listed for EUL on 7 May 2021. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
Similar questions